Lymphodepletion with CD45 Radioimmunotherapy as a Targeted Conditioning Regimen Prior to Adoptive Cell Therapy or CAR-T
Notice bibliographique
Résumé
Lymphodepletion, using chemotherapy such as fludarabine and cyclophosphamide (flu/cy), is recognized as a critical step to create a favorable immune homeostatic environment in patients prior to adoptive cell therapy (ACT) or CAR-T. However, flu/cy is a cytotoxic and non-specific regimen that some patients may not be able to tolerate and is also correlated with cytokine release syndrome (CRS) and possibly neurotoxicity that can occur following CAR-T administration. Targeted lymphodepletion with radioimmunotherapy (RIT) directed to CD45 may be a safer and more effective alternative to target and deplete immune cells, including immune suppressor cells and those implicated in CRS. It may also reduce tumor burden since CD45 is overexpressed on most types of leukemia and lymphoma. The CD45 antigen is found on all nucleated immune cells with increased expression on mature lymphoid and myeloid lineages. Anti-CD45 RIT, 131I -apamistamab (BC8), is in a Phase III clinical trial as a myeloablative targeted conditioning regimen prior to allogeneic stem cell transplant in patients with active relapsed/refractory AML. Results from patients during dosimetry testing have shown that low non-myeloablative doses of 131I-apamistamab were able to safely induce transient lymphopenia; low dose anti-CD45 RIT may therefore be a promising targeted modality to effectively lymphodeplete prior to ACT. Studies were performed with an 131I-labeled anti-mouse CD45 antibody at varying non-myeloablative doses to investigate the effect of CD45-RIT targeted lymphodepletion on immune cell types and cytokine profiles. Following single dose administration of 50 to 200 mCi CD45-RIT, blood, spleen and bone marrow samples were collected from C57Bl/6 mice at 2 days and 4 days post-treatment for immunophenotyping and cytokine profiling. CD45-RIT was shown to mediate effective lymphodepletion of greater than 90% of lymphocytes (CD4 and CD8 T cells, CD19 B cells, and NK cells), but also CD4+, CD25+, FoxP3+ Tregs at doses that had negligible impact on bone marrow stem cells. Notably, in follow-up recovery studies, significant Treg suppression was sustained for at least 10 days post-lymphodepletion. CD45-RIT lymphodepletion also led to reductions in both MDSCs and other immune subsets. Concomitant with effective removal of cytokine sinks, levels of IFNg and IL-6 were unchanged in these non-tumor bearing mice. Although modest, trends for increased IL-15 levels in peripheral blood following targeted lymphodepletion were also observed. Results of CD45-RIT targeted conditioning prior to ACT in the E.G7/OT1 animal model will also be presented. These results demonstrate that targeted lymphodepletion with CD45 RIT can be achieved in a safe and effective manner supporting advancement to clinical testing of a single, low-dose, outpatient regimen (Iomab-ACT) that may effectively replace flu/cy conditioning prior to CAR-T.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,000 | 0,000 |
| Méta-épidémiologie (sens strict) | 0,001 | 0,000 |
| Méta-épidémiologie (sens large) | 0,001 | 0,000 |
| Bibliométrie | 0,001 | 0,001 |
| Études des sciences et des technologies | 0,001 | 0,000 |
| Communication savante | 0,001 | 0,000 |
| Science ouverte | 0,001 | 0,000 |
| Intégrité de la recherche | 0,001 | 0,002 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,004 | 0,001 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».